Optiver Holding
CGEM icon

Optiver Holding’s Cullinan Oncology CGEM Stock Holding History

Optiver Holding’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55K Sell
140
-264
-65% -$3.92K ﹤0.01% 2239
2026
Q1 		$5.74K Buy
404
+204
+102% +$2.62K ﹤0.01% 1370
2025
Q4 		$2.07K Sell
200
-264
-57% -$2.38K ﹤0.01% 1999
2025
Q3 		$2.75K Buy
+464
New +$3.4K ﹤0.01% 2239

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Optiver Holding's CGEM Position: Q2 2026 in Review

Optiver Holding reduced its Cullinan Oncology (CGEM) stake by 65% in Q2 2026, selling an estimated $3.92K and leaving 140 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2239.

Optiver Holding first reported a position in CGEM in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.74K in Q1 2026. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Optiver Holding held 140 shares of Cullinan Oncology worth $2.55K as of Q2 2026.
  • Optiver Holding sold 264 Cullinan Oncology shares in Q2 2026, an estimated $3.92K.
  • Cullinan Oncology made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2239 holding.
  • Optiver Holding first reported a position in Cullinan Oncology in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Cullinan Oncology position peaked at $5.74K in Q1 2026.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.